TEST BANK FOR PHARMACOTHERAPEUTICS FOR
ADVANCED PRACTICE: A PRACTICAL APPROACH, 5TH
EDITION
Virginia Poole Arcangelo et al. • ISBN 9781975160593 • Chapters 1–56 • 250 Original Exam-Style
Questions • 2026/2027 Study Edition
1. Issues for the Practitioner in Drug Therapy
1. Which factor is most important when selecting drug therapy?
Whether samples are available
Whether the drug is heavily advertised
The patient's diagnosis, comorbidities, preferences, and goals
The newest available drug regardless of evidence
2. Which action best reduces prescribing errors?
Rely only on the patient's memory
Perform medication reconciliation and verify allergies before prescribing
Copy the previous prescription without review
Avoid documenting over-the-counter products
3. Clinical judgment in prescribing should include consideration of:
Only drug acquisition cost
Only the prescriber's preference
Expected benefit, harm, monitoring, adherence, and cost
Only the medication's brand name
4. A medication history should include:
Only medications taken in the last 24 hours
Only prescription drugs
Only drugs prescribed by specialists
Prescription, nonprescription, herbal, supplement, and recreational substance use
2. Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
5. The pharmacokinetic process that describes drug movement from the administration site
into systemic circulation is:
Metabolism
Excretion
Absorption
Distribution
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 1
, Illustration: original schematic for study use; not a photograph.
6. A drug's volume of distribution is best described as:
The volume of urine produced per day
A theoretical volume relating the amount of drug in the body to its plasma concentration
The amount of drug excreted in stool
The physical size of the liver
7. A competitive antagonist generally:
Irreversibly activates the receptor
Prevents all drug metabolism
Always increases maximal efficacy
Binds a receptor and reduces agonist effects in a surmountable manner
8. For a drug with a narrow therapeutic index, the prescriber should:
Avoid monitoring
Assume small concentration changes are harmless
Use careful dosing and therapeutic monitoring when indicated
Double the starting dose
3. Impact of Drug Interactions and Adverse Events on Therapeutics
9. A pharmacokinetic drug interaction can occur when one drug:
Changes another drug's absorption, metabolism, distribution, or excretion
Changes the tablet color
Changes only the patient's diagnosis
Changes the patient's height
10. A predictable adverse drug reaction that is dose related is generally classified as:
Type B
Type A
Type D only
Type C only
11. When a serious suspected adverse drug reaction occurs, the clinician should first:
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 2
, Wait for the next routine visit
Hide the event from the patient
Stabilize the patient and manage the reaction while documenting and reporting as appropriate
Continue the drug to confirm the diagnosis
12. A CYP450 inhibitor may increase concentrations of a substrate drug by:
Increasing tablet dissolution only
Reducing its metabolic clearance
Increasing renal filtration of the substrate
Blocking all protein binding
4. Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation
13. Compared with adults, neonates may have increased drug exposure because of:
Greater hepatic enzyme activity
Immature renal and hepatic drug-handling systems
Higher total body water in every compartment
Universally faster renal clearance
14. When considering medication during pregnancy, the clinician should:
Stop all medications regardless of indication
Use only herbal products
Balance maternal benefit against fetal risk using current evidence
Assume all medications are safe
15. For a breastfeeding patient, drug selection should consider:
Only the drug's color
Drug transfer into milk and the infant's ability to handle the exposure
Only the tablet size
Only the maternal blood pressure
16. Pediatric dosing is commonly individualized according to:
Weight, age, developmental status, and clinical factors
Adult dose divided by two for every child
Parent preference alone
Body height alone
5. Pharmacotherapy Principles in Older Adults
17. Older adults are more susceptible to adverse drug effects partly because of:
Changes in renal function, body composition, and pharmacodynamics
Increased total body water in all patients
Uniformly increased renal clearance
Complete resistance to receptor effects
18. A practical prescribing principle for many older adults is:
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 3
, Start at the maximum dose
Avoid follow-up
Start low and titrate carefully while reassessing benefit and harm
Add multiple drugs simultaneously
Illustration: original schematic for study use; not a photograph.
19. Polypharmacy increases risk for:
Drug interactions, adverse effects, and medication errors
Fewer contraindications
Lower adherence burden
Guaranteed therapeutic success
20. Before adding a medication in an older adult, the clinician should ask:
Whether an existing medication can be stopped or simplified
Whether every drug can be doubled
Whether monitoring can be eliminated
Whether the patient can be excluded from the decision
6. Principles of Antimicrobial Therapy
21. The most appropriate antimicrobial strategy is to:
Use an agent active against the likely pathogen and narrow therapy when culture data permit
Continue antibiotics indefinitely
Use antibiotics for every viral syndrome
Always use the broadest possible spectrum
22. Antimicrobial stewardship primarily aims to:
Eliminate cultures
Optimize treatment while minimizing resistance and avoidable harm
Use combination therapy for every infection
Increase antibiotic exposure in all patients
23. A bactericidal drug:
Kills susceptible bacteria
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 4
ADVANCED PRACTICE: A PRACTICAL APPROACH, 5TH
EDITION
Virginia Poole Arcangelo et al. • ISBN 9781975160593 • Chapters 1–56 • 250 Original Exam-Style
Questions • 2026/2027 Study Edition
1. Issues for the Practitioner in Drug Therapy
1. Which factor is most important when selecting drug therapy?
Whether samples are available
Whether the drug is heavily advertised
The patient's diagnosis, comorbidities, preferences, and goals
The newest available drug regardless of evidence
2. Which action best reduces prescribing errors?
Rely only on the patient's memory
Perform medication reconciliation and verify allergies before prescribing
Copy the previous prescription without review
Avoid documenting over-the-counter products
3. Clinical judgment in prescribing should include consideration of:
Only drug acquisition cost
Only the prescriber's preference
Expected benefit, harm, monitoring, adherence, and cost
Only the medication's brand name
4. A medication history should include:
Only medications taken in the last 24 hours
Only prescription drugs
Only drugs prescribed by specialists
Prescription, nonprescription, herbal, supplement, and recreational substance use
2. Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
5. The pharmacokinetic process that describes drug movement from the administration site
into systemic circulation is:
Metabolism
Excretion
Absorption
Distribution
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 1
, Illustration: original schematic for study use; not a photograph.
6. A drug's volume of distribution is best described as:
The volume of urine produced per day
A theoretical volume relating the amount of drug in the body to its plasma concentration
The amount of drug excreted in stool
The physical size of the liver
7. A competitive antagonist generally:
Irreversibly activates the receptor
Prevents all drug metabolism
Always increases maximal efficacy
Binds a receptor and reduces agonist effects in a surmountable manner
8. For a drug with a narrow therapeutic index, the prescriber should:
Avoid monitoring
Assume small concentration changes are harmless
Use careful dosing and therapeutic monitoring when indicated
Double the starting dose
3. Impact of Drug Interactions and Adverse Events on Therapeutics
9. A pharmacokinetic drug interaction can occur when one drug:
Changes another drug's absorption, metabolism, distribution, or excretion
Changes the tablet color
Changes only the patient's diagnosis
Changes the patient's height
10. A predictable adverse drug reaction that is dose related is generally classified as:
Type B
Type A
Type D only
Type C only
11. When a serious suspected adverse drug reaction occurs, the clinician should first:
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 2
, Wait for the next routine visit
Hide the event from the patient
Stabilize the patient and manage the reaction while documenting and reporting as appropriate
Continue the drug to confirm the diagnosis
12. A CYP450 inhibitor may increase concentrations of a substrate drug by:
Increasing tablet dissolution only
Reducing its metabolic clearance
Increasing renal filtration of the substrate
Blocking all protein binding
4. Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation
13. Compared with adults, neonates may have increased drug exposure because of:
Greater hepatic enzyme activity
Immature renal and hepatic drug-handling systems
Higher total body water in every compartment
Universally faster renal clearance
14. When considering medication during pregnancy, the clinician should:
Stop all medications regardless of indication
Use only herbal products
Balance maternal benefit against fetal risk using current evidence
Assume all medications are safe
15. For a breastfeeding patient, drug selection should consider:
Only the drug's color
Drug transfer into milk and the infant's ability to handle the exposure
Only the tablet size
Only the maternal blood pressure
16. Pediatric dosing is commonly individualized according to:
Weight, age, developmental status, and clinical factors
Adult dose divided by two for every child
Parent preference alone
Body height alone
5. Pharmacotherapy Principles in Older Adults
17. Older adults are more susceptible to adverse drug effects partly because of:
Changes in renal function, body composition, and pharmacodynamics
Increased total body water in all patients
Uniformly increased renal clearance
Complete resistance to receptor effects
18. A practical prescribing principle for many older adults is:
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 3
, Start at the maximum dose
Avoid follow-up
Start low and titrate carefully while reassessing benefit and harm
Add multiple drugs simultaneously
Illustration: original schematic for study use; not a photograph.
19. Polypharmacy increases risk for:
Drug interactions, adverse effects, and medication errors
Fewer contraindications
Lower adherence burden
Guaranteed therapeutic success
20. Before adding a medication in an older adult, the clinician should ask:
Whether an existing medication can be stopped or simplified
Whether every drug can be doubled
Whether monitoring can be eliminated
Whether the patient can be excluded from the decision
6. Principles of Antimicrobial Therapy
21. The most appropriate antimicrobial strategy is to:
Use an agent active against the likely pathogen and narrow therapy when culture data permit
Continue antibiotics indefinitely
Use antibiotics for every viral syndrome
Always use the broadest possible spectrum
22. Antimicrobial stewardship primarily aims to:
Eliminate cultures
Optimize treatment while minimizing resistance and avoidable harm
Use combination therapy for every infection
Increase antibiotic exposure in all patients
23. A bactericidal drug:
Kills susceptible bacteria
Pharmacotherapeutics for Advanced Practice — 250-question original practice bank Page 4
